Nephrology Doctors in South Bend, IN Accepting Medicare

2 Nephrology doctors found. Showing 1 - 2

Dr. Syed Mohsan Rizvi, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2235 Cleveland Rd, South Bend, IN 46628 Phone: 574-647-4530    Fax: 574-647-2285

Dr. Mark Alan Richter, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 3116 Robinhood Ln, South Bend, IN 46614 Phone: 574-287-4654

News Archive

Making New Year's resolution to quit smoking a reality

Each year on January 1st, Americans make goals for the New Year, ranging from getting in shape and spending more time with their families to decreasing debt. This year, make a resolution that will not only improve your health, but also save you money— quit smoking. According to the Surgeon General's most recent tobacco-related report, cigarette smoking is the leading cause of preventable disease and premature death worldwide.

Health officials rule out sprouts as source of German E. coli outbreak

Health officials in Germany are continuing to search for the source of an E. coli outbreak after tests on suspected sprouts from a farm in the north of the country came back negative, Deutsche Welle reports. The outbreak has killed 22 people and sickened more than 2,000 (Hallam/Penfold, 6/6).

Transcatheter heart valve replacement recipient celebrates 102nd birthday

When Doris Snyder celebrated her 102nd birthday on August 10, she was that much closer to the expected birth of her first great-granddaughter who's due to arrive early September. She is very excited about the milestone, which might not have been possible were it not for a cutting-edge, experimental procedure that replaced one of Doris' heart valves weeks earlier when she was 101. The valve had been rendered useless by aortic valve stenosis—hardening from calcium deposits that restrict the flow of blood from the heart.

Positive top-line results from Teva's GALA Phase III trial on RRMS

Teva Pharmaceutical Industries Ltd. today announced positive top-line results from the GALA (Glatiramer Acetate Low-Frequency Administration) Phase III clinical trial assessing the efficacy, safety and tolerability of 40 mg/1 ml glatiramer acetate injection (GA) administered subcutaneously three times a week compared to placebo in relapsing-remitting multiple sclerosis (RRMS) patients.

Changes in drinking and smoking during England's first COVID-19 lockdown

The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 infection in early 2020 prompted many nations to close their borders and institute mandatory lockdowns. While lockdowns abruptly stopped daily life, researchers from the University College London and the University of Sheffield found drug-seeking behaviors did not.

Read more Medical News

› Verified 1 days ago